FDA allows Enzo to test up to 5 COVID-19 swabs at once

By LabPulse.com staff writers

January 4, 2021 -- Enzo Biochem has received an expansion of its emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to use pooled swab samples with the company's Ampiprobe SARS-CoV-2 test system.

The EUA covers pooled use of Enzo's test with up to five individual upper respiratory swab samples. It also includes pooled samples on three different platforms, including Enzo's Genflex automated high-throughput system.

Testing up to five samples at once can rapidly expand SARS-CoV-2 testing capacity, noted Enzo CEO Elazar Rabbani, PhD. He added that many states are still struggling to improve access to testing.

Copyright © 2021 LabPulse.com

To read this and get access to all of the exclusive content on LabPulse.com, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a LabPulse.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?